Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union

In the European Union, 11% of all MDR-TB cases are eligible for the shorter MDR-TB regimen http://ow.ly/kukg306AcFl

Detalles Bibliográficos
Autores principales: van der Werf, Marieke J., Hollo, Vahur, Ködmön, Csaba, Dara, Masoud, Catchpole, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898943/
https://www.ncbi.nlm.nih.gov/pubmed/28331041
http://dx.doi.org/10.1183/13993003.01992-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898943/
https://www.ncbi.nlm.nih.gov/pubmed/28331041
http://dx.doi.org/10.1183/13993003.01992-2016

Ejemplares similares